Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on March 27, 2026

Mar. 27, 2026

Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting

Indeterminate GlobeNewswire

Mar. 27, 2026

Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026

Indeterminate GlobeNewswire

Mar. 27, 2026

AI Is Reshaping Neuroprotective Drug Discovery Market: New BCC Research Pulse Report Maps the Investment and Innovation Landscape

Indeterminate GlobeNewswire

Mar. 27, 2026

Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138

Indeterminate GlobeNewswire

Mar. 27, 2026

First therapy funded by California taxpayer dollars is approved to treat rare childhood disorder

Indeterminate GlobeNewswire

Mar. 27, 2026

Lighthouse Autism Center Opening New Autism Therapy Center in Asheboro, North Carolina

Indeterminate GlobeNewswire

Mar. 27, 2026

SafeSpace Global to Attend NIC Spring Conference to Engage Senior Living and Healthcare Leaders

Indeterminate GlobeNewswire

Mar. 27, 2026

Navigator Medicines Advances NAV-240 into Phase 2a and NAV-242 into the Clinic, Supported by New Positive Data Presented at American Academy of Dermatology (AAD) Annual Meeting 2026

Indeterminate GlobeNewswire

Mar. 27, 2026

Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

Indeterminate GlobeNewswire

Mar. 27, 2026

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

Indeterminate GlobeNewswire

Mar. 27, 2026

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update

Indeterminate GlobeNewswire

Mar. 27, 2026

Axe Compute to Host Annual Report Conference Call

Indeterminate GlobeNewswire

Mar. 27, 2026

Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test

Indeterminate GlobeNewswire

Mar. 27, 2026

ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC

Indeterminate GlobeNewswire

Mar. 27, 2026

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2

Indeterminate GlobeNewswire

Mar. 27, 2026

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

Indeterminate GlobeNewswire

Mar. 27, 2026

Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

Indeterminate GlobeNewswire

Mar. 27, 2026

Communiqué de presse : La formulation sous-cutanée de Sarclisa de Sanofi, administrée via un injecteur portable, est recommandée par le CHMP pour approbation dans l'UE dans le traitement du myélome multiple

Indeterminate GlobeNewswire

Mar. 27, 2026

OXB recognised as ‘Most Innovative CDMO (Cell & Gene)’ at 2026 CDMO Leadership Awards

Indeterminate GlobeNewswire

Mar. 27, 2026

Vor Bio Announces $75 Million Private Placement with TCGX

Indeterminate GlobeNewswire